RSS   Newsletter   Contact   Advertise with us
Post Online Media

Physiomics director Mark Chadwick to leave

PhysiomicsPhysiomics, a healthcare company, announced that Mark Chadwick, currently a non-executive director, will be leaving the company.
Article continues below

READ MORE Physiomics appoints James Simon Millen as CEO

Mr. Chadwick served as CEO of Physiomics from December 2010 to April 2016. He was VP of Business Development at Excelsyn, a chemistry services provider, which was subsequently acquired by AMRI.

Before joining Excelsyn, Mr. Chadwick spent 10 years in Cambridge from startup company Cambridge Genetics Limited through two mergers to become Director of Commercial Operations at BioFocus.

Mr. Chadwick is a former Fellow of Corpus Christi College Cambridge.

He holds an MBA with distinction in Entrepreneurship from Imperial College London, a PhD in Molecular Biology from The University of Newcastle and a 1st Class (Hons) degree in Genetics from the University of Nottingham.

He is now non-executive director of Physiomics.

 LATEST MOVES FROM United Kingdom 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy